Piazza, R., Magistroni, V., Tornaghi, L., Andreoni, F., Bungaro, S., Cazzaniga, G., et al. (2003). Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR). In ASH 2003; 45th Congress of the American Society of Hematology (pp.319-319). W.B. Saunders.

Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR)

PIAZZA, ROCCO GIOVANNI;MAGISTRONI, VERA;CAZZANIGA, GIOVANNI ITALO;BIONDI, ANDREA;POGLIANI, ENRICO MARIA;CORNEO, GIANMARCO;GAMBACORTI PASSERINI, CARLO
2003

abstract + poster
Imatinib, Resistance, Complete Cytogenetic Response
English
45th Annual Meeting of the American Society of Hematology
Piazza, R., Magistroni, V., Tornaghi, L., Andreoni, F., Bungaro, S., Cazzaniga, G., et al. (2003). Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR). In ASH 2003; 45th Congress of the American Society of Hematology (pp.319-319). W.B. Saunders.
Piazza, R; Magistroni, V; Tornaghi, L; Andreoni, F; Bungaro, S; Cazzaniga, G; Biondi, A; Pogliani, E; Varella Garcia, M; Corneo, G; GAMBACORTI PASSERINI, C
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/37825
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact